$GILD not much longer now. Official Title: A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate COVID-19 Compared to Standard of Care Treatment Actual Study Start Date : March 15, 2020 Estimated Primary Completion Date : May 2020 Estimated Study Completion Date : May 2020
  • 6